In this webinar, we will investigate if brain atrophy could be used as a biomarker of the disease that can resolve the clinico-radiological paradox and predict the outcome.
Grey Matter Atrophy in MS
Feb 16th, 2022Dec 31st, 1969
Latest in Home
DL algorithm estimates lung nodule cancer risk, reduces false positives
September 18, 2025
Neuroinflammation persists for 2 years in long COVID
September 17, 2025
ChatGPT gathers momentum in MR imaging
September 16, 2025
Low-dose CT ties emphysema to mortality in previous smokers
September 16, 2025